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Regulation of the Phosphorylation State
and Microtubule-Binding Activity of Tau
by Protein Phosphatase 2A
Estelle Sontag,*† Viyada Nunbhakdi-Craig,* phosphatases act on tau invitro, the enzymes regulating
tau phosphorylation in vivo are not known.Gloria Lee,‡ George S. Bloom,§ and Marc C. Mumby*
*Department of Pharmacology PP2A is a heterotrimeric holoenzyme that exists in
multiple forms composed of a common core structure†Department of Pathology
§Department of Cell Biology and Neuroscience bound to different regulatory subunits (Mumby and Wal-
ter, 1993). The core enzyme is a complex between theUniversity of Texas
Southwestern Medical Center catalytic (C) and structural (A) subunits. The third class
of subunit, termed B, comprises several polypeptidesDallas, Texas 75235
‡Center for Neurologic Diseases that regulate PP2A activity and specificity (Mumby and
Walter, 1993; Kamibayashi et al., 1991, 1994). PP2A alsoBrigham and Women’s Hospital
and Harvard Medical School interacts with DNA tumor virus proteins, including SV40
small t. Association of small t with the AC core inhibitsBoston, Massachusetts 02115
the activity of PP2A in vitro (Yang et al., 1991) and in
CV-1 cells (Sontag et al., 1993).
A significant portion of the ABaC isoform of PP2A isSummary
associated with neuronal microtubules (Sontag et al.,
1995), raising the possibility that PP2A regulates theRecently, we reported that a pool of protein phospha-
phosphorylation state of MAPs, such as tau. To assesstase 2A (PP2A) is associated with microtubules. Here,
this possibility, we analyzed interactions between tauwe demonstrate that specific isoforms of PP2A bind
and PP2A in vitro and in intact cells expressing humanand dephosphorylate the neuronal microtubule-asso-
tau. PP2A containing the Ba or Bb regulatory subunits,ciated protein tau. Coexpression of tau and SV40 small
but not other forms of PP2A, bound and potently de-t, a specific inhibitor of PP2A, in CV-1, NIH 3T3, or NT2
phosphorylated tau in vitro. In cells transfected with tau,cells induced the phosphorylation of tau at multiple
coexpression of wild-type small t induced hyperphos-sites, including Ser-199, Ser-202, Thr-205, Ser-396,
phorylation of tau, dissociation of tau from microtubules,and Ser-404. Immunofluorescent and biochemical
and a loss of tau-induced microtubule stabilization.analyses revealed that hyperphosphorylation corre-
lated with dissociation of tau from microtubules and
a loss of tau-induced microtubule stabilization. Taken Results
together, these results support the hypothesis that
PP2A controls the phosphorylation state of tau in vivo. PP2A Binds to Tau In Vitro
Binding of PP2A to tau was assayed in vitro by mobility
shifts during nondenaturating gel electrophoresis andIntroduction
Western blot analysis with antibodies against PP2A sub-
units (Figure 1). In the absence of tau, purified ABaCThe structure and stability of neuronal microtubules is
holoenzyme migrated as two bands recognized by aregulated by microtubule-associated proteins (MAPs),
monoclonal antibody against theC subunit. Comparableincluding tau. Tau is a developmentally regulated phos-
Western blots with antibodies against the A and Baphoprotein that promotes assembly and stability of mi-
subunits indicated that the upper band correspondedcrotubules in vitro and in vivo (reviewed by Goedert,
to the ABaC heterotrimer and the lower band corre-1993). A number of the phosphorylation sites in tau have
sponded to the AC complex generated by dissociationbeen identified using phosphorylation-sensitive anti-
of the heterotrimer during electrophoresis (Mumby etbodies (reviewed by Goedert et al., 1995a) and mass
al., 1987; Kamibayashi et al., 1991). Incubation of PP2Aspectrometry (Morishima-Kawashima et al., 1995). The
with purified bovine brain tau prior to electrophoresispaired helical filaments (PHFs) in Alzheimer’s disease
resulted in a shift of the ABaC band to a form with slower(AD) neurofibrillary tangles are composed of hyperphos-
mobility. In contrast, the mobility of the AC dimer wasphorylated tau (reviewed by Goedert, 1993), and hyper-
unaffected by tau. This suggested that ABaC, but notphosphorylation is associated with a decreased ability
AC, interacted with tau to form a larger complex. Forma-of tau to bind microtubules (Bramblett et al., 1993). Nine
tion of an ABaC–tau complex was confirmed by blottingsites that are hyperphosphorylated in PHF–tau are Ser/
with anti-tau antibody, which specifically labeled a bandThr–Pro sequences (Lee et al., 1991; Biernat et al., 1992),
with mobility identical to the anti-C subunit reactivesuggesting that disregulation of proline-directed ki-
band generated in the presence of tau.nases or corresponding phosphatases (Drewes et al.,
1993; Gong et al., 1994) occurs in AD. Recent evidence
suggests that tau phosphatase activity in AD brain is Specific Isoforms of PP2A Interact with Tau
The specificity of PP2A interaction was addressed bydecreased relative to normal brain (Gong et al., 1995).
Serine/threonine phosphatases, including PP2A, PP2B, comparing the extent of complex formation between
various multimeric forms and individual subunits withand PP1, are capable of dephosphorylating tau in vitro
(Goedert et al., 1992, 1995c; Drewes et al., 1993; Gong purified bovine brain tau (Figure 1). Formation of a com-
plex could not be detected when the AC heterodimeret al., 1994, 1995; Yamamoto et al., 1995) and in situ
(Saito et al., 1995). Although a variety of kinases and and tau were incubated at equimolar concentrations.
Neuron
1202
Figure 1. Tau-Binding Properties of Mono-
meric Subunits and Multimeric Forms of
PP2A
Purified ABaC, ABbC, AB9C, AC–small t (AC/
St), AC, A, Ba, and C were incubated for 15
min on ice with (lanes marked plus) or without
(lanes marked minus) 300 nM purified bovine
brain tau. The samples were analyzed by non-
denaturating gel electrophoresis and West-
ern blotting with either anti-C, anti-Ba, anti-A,
or Tau-1 antibodies. Binding was performed
with 255 nM ABaC, 256 nM ABbC, 482 nM
AB9C, or 400 nM AC/St. No binding was ob-
served with lower concentrations of AB9C or
higher concentrations of AC/St. Tau was also
incubated with the dimeric form of PP2A
present at 400 nM (AC) or 800 nM (ACex) and
with free A (800 nM), Ba (738 nM), or C (1.84
mM) subunits. Thick arrows indicate the pres-
ence of PP2A–tau complexes. Dissociated
AC dimer is indicated by open arrows in pan-
els ABaC, ABbC, and AC/St. AC dimers did
not dissociate from AB9C because of the
higher affinity of B9 for AC. Similar results
were obtained in four separate experiments.
However, when tau was incubated with an excess of instead of PKA. The ability to dephosphorylate tau was
closely correlated with the ability of the different iso-AC (ACex), a small amount of a shifted band correspond-
ing to an AC–taucomplex could bedetected. In contrast, forms to bind to tau. These observations, along with the
results shown in Figure 1, indicate that the Ba or Bbnone of the individual subunits of PP2A interacted to
any detectable extent with tau, even when present in regulatory subunitspromote efficient enzymological and
structural interactions between PP2A and tau.excess. These results indicate that the minimal structure
required for binding of PP2A to tau is the AC complex
and that higher affinity binding occurs with the hetero- Inhibition of PP2A Activity Induces Phosphorylation
of Tau at PHF-Associated Epitopestrimer containing the Ba subunit. Thus, regulatory sub-
units play an important role in specifying interaction of To address the role of PP2A in controlling tau phosphor-
ylation in a cellular environment, we suppressed PP2APP2A with tau.
To determine whether different regulatory subunits activity by overexpressing small t in cultured cells. Small
t displaces the endogenous Ba subunit of PP2A whenspecifically target PP2A to tau, we tested the abilities
of the Bb subunit, the B9 subunit, and small t to promote expressed at high levels in CV-1 cells, resulting in inhibi-
tion of PP2A activity (Sontag et al., 1993). CV-1 cellsbinding of PP2A to tau. The ABbC holoenzyme bound
to tau as efficiently as ABaC, as judged by the disap-
pearance of the ABbC band and formation of the corre-
sponding ABbC–tau complex. In contrast, the AB9C ho-
loenzyme was only partially shifted to the AB9C–tau
complex, and only at higher PP2A concentrations. The
AC–small t complex was not able to associate with tau
in these assays. Similar results were obtained when
binding was carried out using recombinant heterotri-




PP2A dephosphosphorylates tau phosphorylated in
vitro by several protein kinases including protein kinase
A (PKA) and MAP kinase (Goedert et al., 1995c). Based Figure 2. Dephosphorylation of Tau by Specific Forms of PP2A
on our findings that PP2A binds to tau in an isoform- Dephosphorylation of PKA-phosphorylated recombinant tau (200
nM) was performed by incubation for 5 min at 308C with 40 nMspecific manner, the ability of PP2A isoforms to dephos-
ABaC, ABbC, AB9C, AC–small t (AC/St), AC, or free C and analyzedphorylate tau in vitro were compared. Figure 2 shows
as described in Experimental Procedures. Results are expressedthat ABaC and ABbC had high activity toward tau phos-
as the percentage of maximal tau phosphorylation obtained in thephorylated by PKA. In contrast, AC and AB9C only par-
absence of the phosphatase (lane marked minus). Comparable re-
tially dephosphorylated tau, whereas the free C subunit sults were obtained in two other experiments and when bovine brain
and AC–small t had very low activity. Similar results were tau, instead of recombinant tau, was used in the dephosphorylation
assays.obtained when tauwas phosphorylated with MAP kinase
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Figure 3. Expression of Small t Induces Phosphorylation of Tau
CV-1 cells were cotransfected with pEn1234c encoding human adult tau plus either pCMV5 alone (C), or pCMV5–small t (St), and processed
for immunofluorescence using anti-tubulin, or the Tau-2, Tau-1, AT-8, or PHF-1 tau monoclonal antibodies. Scale bars, 15 mm.
were cotransfected with expression plasmids encoding antibody (Biernat et al., 1992; Goedert et al., 1995b),
was observed in cells expressing small t. A similar smallhuman adult tau and small t. The distribution and
phosphorylation status of tau were determined 48 hr t–induced increase in tau immunoreactivity was ob-
served with antibody PHF-1, which recognizes an epi-after transfection by immunofluorescence using anti-
tau monoclonal antibodies directed against individual tope containing the phosphorylated forms of Ser-396
and Ser-404 (Greenberg et al., 1992).phosphorylation sites (Figure 3). Although only results
with CV-1 cells are presented here, similar data were Phosphorylation of individual sites on tau was verified
by Western blot analysis (Figure 4A). Expressed tau wasobtained with NIH 3T3 fibroblasts and human NT2 neu-
ronal precursor cells. detected as multiple bands resulting from differential
phosphorylation, as reported previously (Lee and Rook,When expressed by itself, tau associated with endog-
enous microtubules and caused microtubule bundling, 1992). The phosphorylation-dependent antibodies AT-8,
PHF-1, and T3P reacted strongly with tau isolated fromas observed previously (Lee and Rook, 1992). Microtu-
bule bundles were detected with either anti-tubulin or small t–expressing cells, but not from control cells.
These differences in immunoreactivity did not resultanti-tau antibodies. Double labeling experiments con-
firmed that the ABaC heterotrimer colocalized with from discrepancies in the level of tau expression, since
immunoblotting with the phosphorylation-independenttransfected tau on the microtubule bundles (data not
shown). Immunofluorescence with Tau-1 antibody, Tau-2 antibody (Papasozomenos and Binder, 1987)
showed that equivalent amounts of tau were expressedwhich specifically recognizes the dephosphorylated
form of an epitope that encompasses Ser-199 and Ser- in control and small t transfected cells. Immunoblotting
with small t antibodies verified that small t was ex-202 (Binder et al., 1985; Papasozomenos and Binder,
1987), showed that this epitope was largely in a dephos- pressed in the transfected cells. Along with the immuno-
fluorescence data (Figure 3), these results indicate thatphorylated form. Coexpression of tau with small t dra-
matically altered tau localization and immunoreactivity. small t caused the phosphorylation of multiple sites in
tau including Ser-199, Ser-202, Thr-205, Ser-396, andIn the majority of cells that expressed small t, tau was
present in a diffuse cytoplasmic pattern, consistent with Ser-404.
Hyperphosphorylation of tau is associated with a shiftdissociation of tau from microtubules. Loss of microtu-
bule-bound tau was not due to disruption of the microtu- in its electrophoretic mobility (Lee et al., 1991). Consis-
tent with increased phosphorylation, coexpressed smallbule network, since intact microtubules were detected
with anti-tubulin antibody. However, in contrast with t caused a decrease in the electrophoretic mobility of tau
(Figure 4B, lanes 1 and 2). A similar effect was observedcells transfected with tau alone, no microtubule bundles
were visible in these cells. The Tau-1 antibody did not when tau-expressing cells were treated with the phos-
phatase inhibitor okadaic acid (Figure 4B, lane 6). Fur-detect tau in most cells expressing small t, indicating
that dissociation of tau from microtubules coincided ther evidence for the involvement of PP2A in small
t–induced phosphorylation of tau was obtained usingwith extensive phosphorylation of Ser-199 and Ser-202.
A striking increase in phosphorylation of the epitope small t mutants (Sontag et al., 1993). Coexpression of
a small t mutant that is deficient in binding to PP2Acontaining Ser-202 and Thr-205, recognized by the AT-8
Neuron
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Figure 4. Inhibition of PP2A Causes the Phosphorylation of Multiple
Sites on Tau and a Shift in Electrophoretic Mobility
(A) CV-1 cells transfected with tau alone (C) or in addition to small
t (ST) were analyzed by Western blotting with the same antibodies
used in Figure 3, as well as with the tau antibody T3P, which specifi-
cally recognizes an epitope containing the phosphorylated form of
Ser-396 (Lang et al., 1992; Bramblett et al., 1993). Expression of
small t was detected by immunoblotting with monoclonal pAb419
antibody (Sontag et al., 1993). Shown here are representative results
from one of three experiments.
(B) CV-1 cells were transfected with tau alone (lane 1), or in combina-
tion with wild-type small t (lane 2), or small t mutant 3 (lane 3),
mutant 5 (lane 4), or mutant 8 (lane 5). Cells transfected with tau
alone were also incubated for 30 min with 500 nM okadaic acid
(lane 6). Cells were harvested for Western blot analysis, and tau
was detected with Tau-2 antibody. Similar results were obtained in
two other experiments.
(mutant 3) did not alter the mobility of tau (Figure 4B,
lane 3). In contrast, two mutants that are capable of
binding to and inhibiting PP2A (mutants 5 and 8) were
Figure 5. Small t–induced Hyperphosphorylation Inhibits the Micro-
as potent as wild-type small t (Figure 4B, lanes 4 and tubule-Binding and Microtubule-Stabilizing Activities of Tau
5). When tested with phosphorylation site-specific anti- (A) CV-1 cells expressing tau alone (Control) or in addition to small
bodies, mutant 8, but not mutant 3, caused the phos- t (Small t) were detergent extracted as described in Experimental
phorylation of tau at the same epitopes induced by wild- Procedures. The soluble extracts (S) and insoluble cytoskeletal frac-
tions (I) were analyzed for tau by SDS gel electrophoresis and West-type small t (data not shown). The effects of the mutants
ern blotting with Tau-2 antibody.show that hyperphosphorylation of tau is dependent on
(B) CV-1 cells transfected with tau alone (C) or cotransfected with tauinteraction of small t with PP2A.
and small t (St) were incubated for 20 min with 3.3 mM nocodazole.
Detergent-resistant cytoskeletons were then isolated and pro-
Small t–Induced Hyperphosphorylation of Tau Causes cessed for immunofluorescence using anti-tubulin or Tau-2antibod-
a Loss in Microtubule-Binding and Stabilization ies. Scale bars, 12 mm.
The pattern of tau localization observed in cells coex-
pressing small t suggested that tau was no longer asso- (Drubin and Kirschner, 1986; Lee and Rook, 1992). Small
ciated with microtubules (Figure 3). Therefore, binding t–induced dissociation of tau from microtubules should
of tau to microtubules was examined by Western blot result in increased sensitivity to nocodazole. Therefore,
analysis of soluble and cytoskeletal fractions prepared cells treated with 3.3 mM nocodazole for 20 min were
from control and small t–transfected cells. Figure 5A extracted with a detergent-containing buffer that pre-
shows that tau was recovered in the insoluble cytoskele- serves microtubules, but completely solubilizes disas-
tal fraction from control cells, but in the soluble fraction sembled tubulin (Sontag et al., 1995). Anti-tubulin and
from small t–expressing cells. Thus, small t–induced Tau-2 antibodies were used to stain the resulting cy-
hyperphosphorylation of tau correlates with dissociation toskeletons by immunofluorescence. Figure 5B shows
from microtubules, consistent with previous reports in- that a large proportion of tau was associated with noco-
dicating that hyperphosphorylated tau does not bind to dazole-resistant microtubule bundles in cytoskeletons
microtubules (Bramblett et al., 1993; Biernat et al., 1993). isolated from cells expressing tau alone. In contrast,
The microtubule bundles that form as a result of ex- coexpression of small t with tau resulted in a complete
pression of tau are more resistant than normal micro- loss of Tau-2 immunofluorescence and complete disas-
sembly of microtubules.tubules to depolymerization induced by nocodazole
Regulation of Tau by Protein Phosphatase 2A
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Discussion tau. A decrease in PP2A activity has been observed in
AD relative to normal brains (Gong et al., 1995). Based
on our results, a decrease in constitutive PP2A activityThis report builds upon our finding that a substantial
fraction of the cellular pool of PP2A is associated with could be involved in the production of overly phosphory-
lated forms of tau (see Figures 3–4), leading to a loss ofmicrotubules (Sontag et al., 1995). The fact that PP2A
and tau are colocalized on microtubules in neurons microtubule binding and reduced microtubule stability
(see Figure 5). A defect in PP2A, most likely with theprompted us to investigate whether the two proteins
interact in a physiologicallysignificant manner. As docu- participation of additional cellular factors, could thus
contribute to the induction or maintenance of hyper-mented here, we found that PP2A binds directly to tau
and effectively dephosphorylates tau in vitro. Further- phosphorylated tau found in AD PHFs.
more, suppression of PP2A activity leads to hyperphos-
phorylation of expressed tau in cultured cells. Among Experimental Procedures
the forms of PP2A that were assayed, heterotrimers
Materialscontaining the Ba or Bb regulatory subunits were most
Reagents included Tau-2 (Sigma), AT-8 (Biosource International),efficient at binding and dephosphorylating tau. These
Tau-1 (Dr. Lester Binder, Northwestern University School of Medi-observations are noteworthy, since the ABaC holoen-
cine), T3P (Dr. Virginia Lee, University of Pennsylvania School of
zyme is theprincipal PP2A isoform inbrain (Kamibayashi Medicine), and PHF-1 (Dr. Peter Davies, Albert Einstein College of
et al., 1994), the ABaC form binds to neuronal microtu- Medicine) antibodies to tau; antibodies to PP2A subunits (Mumby
bules (Sontag et al., 1995), and it has much higher tau et al., 1985; Kamibayashi et al., 1991, 1994) and tubulin (Vallee and
Bloom, 1983); pEn1234c for expression of human adult tau (Leephosphatase activity than other forms of PP2A (Goedert
and Rook); and pCMV5 or Rc/CMV expression vectors for small tet al., 1992; Figure 2). A predominant role for PP2A in
proteins (Sontag et al., 1993).the regulation of tau is also supported by studies show-
ing that PP2A is the major brain phosphatase activity
Protein Purificationtoward tau in vitro (Goedert et al., 1995c), that tau is
Previously published methods were used for purification of ABaC,
readily dephosphorylated by PP2A in postmortem brain AB9C, AC, and C from bovine cardiac or brain tissue (Mumby et al.,
tissue (Matsuo et al., 1994), and that PP2A can be coim- 1985, 1987; Kamibayashi et al., 1991) and of recombinant A, Ba,
munoprecipitated from rat brain microtubules using ABaC, ABbC, andsmall t expressed in insect SF9 cells (Kamibayashi
et al., 1994). The AC–small t complex was formed by incubation ofanti-tau antibodies (Morishima-Kawashima and Kosik,
400 nM AC with 1.2 mM small t for 30 min at 308C (Yang et al., 1991).1996).
Tau was purified from heat stable bovine brain MAPs by gel filtrationTo investigate the possibility that PP2A functions as
chromatography (Kim et al., 1979). Recombinant human adult tau
a tau phosphatase in vivo, we examined the behavior was purified as documented earlier (Brandt and Lee, 1993).
of transfected tau in cultured cells cotransfected with
expression vectors for small t, a specific inhibitor of Tau Binding Assay
PP2A. Immunofluorescence and biochemical results in- Purified forms of PP2A in storage buffer (25 mM Tris, 1 mM dithi-
dicated that small t expression led to extensive PHF- othreitol, 1 mM EDTA, 50% glycerol [pH 7.5]) were incubated for 15
min on ice with bovine brain tau, in a final volume of 5 ml. Afterlike phosphorylation of tau at Ser-199, Ser-202, Thr-205,
incubation, the samples were applied directly on precast 8%–25%Ser-396, and Ser-404 epitopes, and dissociation of the
polyacrylamide gels and analyzed by native gel electrophoresis us-highly phosphorylated tau from microtubules. It is possi-
ing the Pharmacia PhastSystem (Mumby et al., 1987; Kamibayashi
ble that additional sites (Morishima-Kawashima et al., et al., 1991, 1994). Proteins were then transferred to nitrocellulose
1995), not examined in our experiments and associated for Western blotting with anti-C, anti-A, anti-Ba, or Tau-1 antibodies.
with decreased affinity of tau for microtubules (Biernat Immunoreactive proteins were detected by the ECL chemilumines-
cence method (Amersham).et al., 1993; Bramblett et al., 1993), also become hyper-
phosphorylated in small t–transfected cells. The effects
Tau Dephosphorylation Assayof small t on tau phosphorylation were due to inhibition
Recombinant tau was phosphorylated by PKA (Sigma) for 2 hr atof PP2A and not to indirect activation of ERK2, which
308C in the presence of 20 mM [g-32P]ATP (4 mCi), 10 mM MgCl2, 1occurs following small t expression in CV-1 cells (Sontag
mM dithiothreitol, and 10 mM cyclic AMP. The reaction mixture was
et al., 1993). This conclusion was supported by the then incubated for 4 min at 908C, for 5 min on ice, and centrifuged
observation that overexpression of either wild-type at 14,000 3 g for 5 min. Tau, present in the resulting supernatant,
or dominant negative ERK2 had no effect on small incorporated z5 mol of phosphate/mol of protein, in agreement with
a previous report (Scott et al., 1993). 32P-labeled tau (200 nM) wast–induced hyperphosphorylation of tau and did not af-
incubated for 5 min at 308C with 40 nM of various forms of PP2A.fect the distribution of tau observed by immunofluores-
Dephosphorylation was halted by addition of 33 SDS sample buffer.cence.
The samples were resolved on 12% SDS–polyacrylamide gels, and
Our results strongly suggest that the ABaC form of 32P incorporation into tau was quantitated using a phosphorimager
PP2A directly regulates tau phosphorylation in vivo. A (Molecular Dynamics).
compelling body of evidence has indicated that PHFs,
a pathological hallmark of AD, assemble in vivo from Cell Culture and Transfection
abnormally hyperphosphorylated forms of tau (reviewed CV-1 and NIH 3T3 cells were cultured inDulbecco’s modified Eagle’s
medium (GIBCO BRL) supplemented with 5% cosmic calf serumby Goedert, 1993). Although the biochemical require-
(HyClone), while the medium for NT2 cells (Stratagene) containedments for PHF formation remain to be defined, it is
10% fetal bovine serum. Dishes (100 mm) were transfected with 20widely believed that abnormal phosphorylation is a key
mg of DNA (5 mg of pEn1234c and 15 mg of plasmids for expression
event in the transformation of normal tau into PHF–tau. of small t proteins) and 50 mg lipofectamine, following the instruc-
A likely trigger for PHF formation, therefore, is a shift in tions of the manufacturer (GIBCO BRL). Under these conditions,
the balance between the neuronal protein kinases and nearly all cells that were cotransfected with tau and small t ex-
pressed both proteins.phosphatases that control the phosphorylation state of
Neuron
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Cell Extraction, Immunofluorescence, and Western Blotting Alzheimer paired helical filaments by calcineurin and phosphatase
2A. FEBS Lett. 336, 425–432.Intact cells or detergent-resistant cytoskeletons (Sontag et al., 1995)
were fixed with methanol and labeled for immunofluorescence mi- Drubin, D.G., and Kirschner, M.W. (1986). Tau protein function in
croscopy, as described previously (Sontag et al., 1995). For Western living cells. J. Cell Biol. 103, 2739–2746.
blot analysis, cells (100 mm dishes) were homogenized 48 hr after
Goedert, M. (1993). Tau protein and the neurofibrillary pathology oftransfection in 400 ml of PEM buffer (0.1 M PIPES, 5 mM MgCl2, Alzheimer’s disease. Trends Neurosci. 16, 460–465.and 2 mM EGTA [pH 6.9]) containing protease and phosphatase
Goedert, M., Cohen, E.S., Jakes, R., and Cohen, P. (1992). p42 MAPinhibitors (1 mM phenylmethylsulfonyl fluoride; 10 mg/ml aprotinin,
kinase phosphorylation sites in microtubule-associated protein tau10 mg/ml leupeptin, 10 mM p-nitrophenylphosphate, 25 mM b-glyc-
are dephosphorylated by protein phosphatase 2A1: implications forerophosphate, 1 mM okadaic acid, 25 mM sodium orthovanadate,
Alzheimer’s disease. FEBS Lett. 312, 95–99.and 10 mM sodium fluoride). To enrich for tau, the lysates were
boiled for 5 min, incubated on ice for 5 min, and centrifuged for 15 Goedert, M., Spillantini, M.G., Jakes, R., Crowther, R.A., Vanmeche-
min at 48C. Aliquots of unboiled cell extracts were saved for separate len, E., Probst, A., Gotz, J., Burki, K., and Cohen, P. (1995a). Molecu-
immunoblotting to verify expression of small t proteins. Equal vol- lar dissection of the paired helical filament. Neurobiol. Aging 16,
umes of soluble proteins (40 ml) were diluted with 33 SDS sample 325–334.
buffer, resolved on 8%–15% gradient SDS–polyacrylamide gels, Goedert, M., Jakes, R., and Vanmechelen, E. (1995b). Monoclonal
transferred to nitrocellulose, and probed with anti-tau antibodies. antibody AT8 recognizes tau protein phosphorylated at both serine
In other experiments, cells (100 mm dishes) were extracted with 202 and threonine 205. Neurosci. Lett. 189, 167–170.
2 ml of buffer to yield a soluble fraction, after which the insoluble
Goedert, M., Jakes, R., Wang, J.H., and Cohen, P. (1995c). Proteincytoskeletal fraction was harvested in an additional 2 ml of buffer.
phosphatase 2A is the major enzyme in brain that dephosphorylatesBoth fractions were boiled for 5 min, incubated on ice for 5 min,
tau protein phosphorylated by proline-directed kinases or cyclicand clarified by centrifugation for 15 min at 48C. Equal volumes (80
AMP–dependent protein kinase. J. Neurochem. 65, 2804–2807.ml) of both fractions were diluted with 63 SDS gel sample buffer,
Gong, C.-X., Singh, T.J., Damuni, Z., and Iqbal, K. (1994). Dephos-resolved on 12% SDS–polyacrylamide gels, transferred to nitrocellu-
phorylation of microtubule-associated protein tau by protein phos-lose, and blotted with Tau-2.
phatase-1 and -2C and its implication in Alzheimer disease. FEBS
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